CCCC vs GD · rev $35.6M vs P/E 22, rev $52.55B
C4 Therapeutics Inc (CCCC) versus General Dynamics Corporation (GD) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
General Dynamics Corporation (GD) is a aerospace & defense company listed on US.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
Latest reported GD revenue for 2025-12-31 was $52.55B. Net income was $4.21B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. GD currently screens at market cap $93.69B and trailing P/E 21.8.
CCCC currently screens at market cap $425.7M. GD currently screens at market cap $93.69B and trailing P/E 21.8.
Not investment advice. Open the CCCC and GD stock pages for the full models.
Not investment advice.